Thank you for Subscribing to CIO Applications Weekly Brief

Advera Health Analytics, a leader in pharmacovigilance, has been acquired by TriNetX.
"Life sciences companies trust Advera for safety signal detection and management," said Brian M. Overstreet, President and CEO of Advera, who will now lead the pharmacovigilance business unit at TriNetX as a senior executive and member of the
By
CIO Applications | Wednesday, February 02, 2022

The goal of the world's biggest real-world data network is to improve medication safety.
Fremont, CA: "Life sciences companies trust Advera for safety signal detection and management," said Brian M. Overstreet, President and CEO of Advera, who will now lead the pharmacovigilance business unit at TriNetX as a senior executive and member of the company's leadership team. "The Evidex platform enables drug safety teams to quickly validate signals through advanced technology, multiple safety datasets, and integrated workflow management tools. Evidex's adoption in the market has led to significant progress in the evolution of pharmacovigilance."
TriNetX is a global system of healthcare organizations and life sciences businesses accelerating the discovery of innovative medicines through real-world research. TriNetX's self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consultancy relationships empowers its global community to enhance protocol design, simplify trial operations, optimize safety signals, and enrich real-world evidence gathering.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
TriNetX obtained Advera Health Analytics, the market leader in pharmacovigilance software applications, to identify, manage, and mitigate drug safety risks.
Advera's purchase, together with its industry-leading Evidex technology, will provide TriNetX clients with a comprehensive picture of drug safety concerns as they occur in real-time. The power of Evidex, as well as the large amount of real-world data on the TriNetX network, will assist life sciences businesses in refining, managing, and validating safety signals with deeper clinical data and more efficient than the sector has previously depended on.
Advera Health Analytics is a global pioneer in pharmacovigilance software, analytics, and data at the forefront of drug safety science. Advera Health developed Evidex, a next-generation pharmacovigilance platform that connects diverse drug safety data sources and provides a user experience that extracts actionable knowledge from that data.
More in News

